...in patients with hereditary antithrombin deficiency. LFB gained the product through its 2010 acquisition of GTC Biotherapeutics Inc....

...NASDAQ:VSTM), Cambridge, Mass. Business: Cancer Hired: John Green as CFO, formerly SVP and CFO of GTC Biotherapeutics Inc....

...Diagnostic Hired: William Heiden as president, CEO and a director, formerly president and CEO of GTC Biotherapeutics Inc....

...million. The once public company is now a subsidiary of LFB (see BioCentury, Nov. 15). GTC Biotherapeutics Inc....

...that day urging the biotech to shelve any defensive actions in response to the offer. GTC Biotherapeutics Inc....

...and reduce headcount by 50 (46%) to 59 to save cash (see BioCentury, June 21). GTC Biotherapeutics Inc....

...and reduce headcount by 50 (46%) to 59 to save cash (see BioCentury, June 21). GTC Biotherapeutics Inc....

...immune responses against cancer cells," said Yann Echelard, VP of corporate and technology development at GTC Biotherapeutics Inc....
...Francisco, Calif. Fresenius SE (Xetra:FRE), Bad Homburg, Germany Genentech Inc. , South San Francisco, Calif. GTC Biotherapeutics Inc....

...to save cash and focus on improving the profitability of ATryn (see BioCentury, June 21). GTC Biotherapeutics Inc....